Japan Begins Over-the-Counter Sales of Emergency Contraceptive Pills

Historic Shift in Reproductive Healthcare

As of Monday, February 1, 2026, Japan has officially begun over-the-counter (OTC) sales of emergency contraceptive pills, a move that significantly broadens access to reproductive healthcare in the country. The emergency contraceptive, known as NorLevo (ノルレボ錠 1.5mg), is now available without a doctor's prescription, an age limit, or the need for parental consent.

Previously, individuals seeking emergency contraception in Japan were required to obtain a prescription from a doctor, often necessitating a visit to a clinic or hospital. This requirement posed logistical and emotional barriers, particularly during weekends or holidays, and for survivors of sexual assault.

Conditions for Purchase and Availability

While the new regulations eliminate the need for a prescription, specific conditions apply to the purchase of NorLevo. Buyers must acquire the pill in person; online sales are not permitted. Furthermore, only the individual intending to use the medication is allowed to purchase it, with agents or men prohibited from buying on behalf of others. The transaction must occur in the presence of a trained pharmacist, who will provide an explanation and ensure proper use.

The Ministry of Health, Labour and Welfare has published a list of approximately 7,000 pharmacies and drugstores that are certified to sell the drug, as of January 31st. These pharmacies must meet certain requirements, including ensuring privacy for buyers and maintaining liaison with nearby obstetrics and gynecology clinics.

Pricing and Effectiveness

The suggested retail price for one tablet of NorLevo is 7,480 yen, which is approximately US$48. Emergency contraceptive pills are most effective when taken within 72 hours of unprotected sexual intercourse, with an efficacy rate of about 80%.

Pathway to OTC Access

The decision to allow OTC sales followed a trial program that began in 2023. This program initially rolled out across 145 pharmacies and expanded to 339 locations by January 2025, during which over 6,813 units were sold. An expert panel of the health ministry approved the shift to OTC sales in late August 2025, paving the way for the nationwide rollout. This change brings Japan closer to international standards, as emergency contraceptives are already available without a prescription in approximately 90 other countries and regions globally.